RJA
ALDR

Raymond James & Associates’s Alder Biopharmaceuticals ALDR Stock Holding History

Raymond James & Associates’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-11,002
Closed -$126K – 3638
2017
Q4 		$126K Buy
11,002
+66
+0.6% +$737 ﹤0.01% 3174
2017
Q3 		$134K Sell
10,936
-406
-4% -$4.23K ﹤0.01% 3144
2017
Q2 		$130K Sell
11,342
-6,847
-38% -$127K ﹤0.01% 3080
2017
Q1 		$378K Buy
18,189
+1,076
+6% +$23.8K ﹤0.01% 2554
2016
Q4 		$356K Buy
17,113
+25
+0.1% +$650 ﹤0.01% 2537
2016
Q3 		$560K Buy
17,088
+2,568
+18% +$78.2K ﹤0.01% 2198
2016
Q2 		$363K Buy
14,520
+2,956
+26% +$80K ﹤0.01% 2293
2016
Q1 		$283K Sell
11,564
-237
-2% -$5.49K ﹤0.01% 2371
2015
Q4 		$390K Buy
11,801
+398
+3% +$13.5K ﹤0.01% 2099
2015
Q3 		$374K Buy
+11,403
New +$485K ﹤0.01% 2051

Other funds holding ALDR

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return